Literature DB >> 15724091

Rosacea: an update.

Stanislaw A Buechner1.   

Abstract

Rosacea is a common chronic cutaneous disorder of unknown etiology which occurs most commonly in middle-aged individuals. Cutaneous manifestations include transient or persistent facial erythema, telangiectasia, edema, papules and pustules that are usually confined to the central portion of the face. The National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea identified four subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous and ocular. Recently, a standard grading system for assessing gradations of the severity of rosacea has been reported. Little is known about the cause of rosacea. Genetic, environmental, vascular, inflammatory factors and microorganisms such as Demodex folliculorum and Helicobacter pylori have been considered. Topical metronidazole and azelaic acid have been demonstrated to be effective treatments for rosacea. Severer or persistent cases may be treated with oral metronidazole, tetracyclines or isotretinoin.

Entities:  

Mesh:

Year:  2005        PMID: 15724091     DOI: 10.1159/000082564

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  18 in total

Review 1.  Rosacea: The cytokine and chemokine network.

Authors:  Peter Arne Gerber; Bettina Alexandra Buhren; Martin Steinhoff; Bernhard Homey
Journal:  J Investig Dermatol Symp Proc       Date:  2011-12

Review 2.  [Rosacea. Clinical features, pathogenesis and therapy].

Authors:  P Lehmann
Journal:  Hautarzt       Date:  2005-09       Impact factor: 0.751

Review 3.  Skin barrier in rosacea.

Authors:  Flavia Alvim Sant'Anna Addor
Journal:  An Bras Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.896

4.  Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-03

5.  A Guide to the Ingredients and Potential Benefits of Over-the-Counter Cleansers and Moisturizers for Rosacea Patients.

Authors:  Jacquelyn Levin; Richard Miller
Journal:  J Clin Aesthet Dermatol       Date:  2011-08

6.  TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes.

Authors:  Kenshi Yamasaki; Kimberly Kanada; Daniel T Macleod; Andrew W Borkowski; Shin Morizane; Teruaki Nakatsuji; Anna L Cogen; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2010-11-25       Impact factor: 8.551

7.  Hydroxocobalamin: An Effective Treatment for Flushing and Persistent Erythema in Rosacea.

Authors:  Yi-Wei Huang; Hui-Peng Huang; Chao-Kai Hsu; Julia Yu-Yun Lee
Journal:  J Clin Aesthet Dermatol       Date:  2022-06

Review 8.  The molecular pathology of rosacea.

Authors:  Kenshi Yamasaki; Richard L Gallo
Journal:  J Dermatol Sci       Date:  2009-05-29       Impact factor: 4.563

9.  Terpinen-4-ol is the Most Active Ingredient of Tea Tree Oil to Kill Demodex Mites.

Authors:  Sean Tighe; Ying-Ying Gao; Scheffer C G Tseng
Journal:  Transl Vis Sci Technol       Date:  2013-11-13       Impact factor: 3.283

10.  Dermatology for the allergist.

Authors:  Dennis Kim; Richard Lockey
Journal:  World Allergy Organ J       Date:  2010-06-15       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.